Literature DB >> 29572088

Predictive Factors for Death After Snake Envenomation in Myanmar.

Kyi-Phyu Aye1, Vipa Thanachartwet2, Chit Soe3, Varunee Desakorn4, Supat Chamnanchanunt4, Duangjai Sahassananda5, Thanom Supaporn6, Visith Sitprija7.   

Abstract

INTRODUCTION: Factors predictive for death from snake envenomation vary between studies, possibly due to variation in host genetic factors and venom composition. This study aimed to evaluate predictive factors for death from snake envenomation in Myanmar.
METHODS: A prospective study was performed among adult patients with snakebite admitted to tertiary hospitals in Yangon, Myanmar, from May 2015 to August 2016. Data including clinical variables and laboratory parameters, management, and outcomes were evaluated. Multivariate regression analysis was performed to evaluate factors predictive for death at the time of presentation to the hospital.
RESULTS: Of the 246 patients with snake envenomation recruited into the study, 225 (92%) survived and 21 (8%) died during hospitalization. The snake species responsible for a bite was identified in 74 (30%) of the patients; the majority of bites were from Russell's vipers (63 patients, 85%). The independent factors predictive for death included 1) duration from bite to arrival at the hospital >1 h (odds ratio [OR]: 9.0, 95% confidence interval [CI]: 1.1-75.2; P=0.04); 2) white blood cell counts >20 ×103 cells·μL-1 (OR: 8.9, 95% CI: 2.3-33.7; P=0.001); and 3) the presence of capillary leakage (OR: 3.7, 95% CI: 1.2-11.2; P=0.02). A delay in antivenom administration >4 h increases risk of death (11/21 deaths).
CONCLUSIONS: Patients who present with these independent predictive factors should be recognized and provided with early appropriate intervention to reduce the mortality rate among adults with snake envenomation in Myanmar.
Copyright © 2018 Wilderness Medical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  prospective study; snakebites

Mesh:

Substances:

Year:  2018        PMID: 29572088     DOI: 10.1016/j.wem.2018.01.001

Source DB:  PubMed          Journal:  Wilderness Environ Med        ISSN: 1080-6032            Impact factor:   1.518


  6 in total

1.  Identifying the snake: First scoping review on practices of communities and healthcare providers confronted with snakebite across the world.

Authors:  Isabelle Bolon; Andrew M Durso; Sara Botero Mesa; Nicolas Ray; Gabriel Alcoba; François Chappuis; Rafael Ruiz de Castañeda
Journal:  PLoS One       Date:  2020-03-05       Impact factor: 3.240

Review 2.  Methodological issues in economic evaluations of emergency transport systems in low-income and middle-income countries.

Authors:  Richard Lilford; Dmitri Nepogodiev; Peter J Chilton; Samuel I Watson; Darius Erlangga; Peter Diggle; Alan J Girling; Mark Sculpher
Journal:  BMJ Glob Health       Date:  2021-03

3.  Pain and Cellular Migration Induced by Bothrops jararaca Venom in Mice Selected for an Acute Inflammatory Response: Involvement of Mast Cells.

Authors:  Fernanda V Kondo; Wafa H K Cabrera; Orlando G Ribeiro; Marcelo De Franco; José Ricardo Jensen; Gisele Picolo; Morena B Sant'Anna; Monica Spadafora-Ferreira; Andrea Borrego; Olga M Ibañez; Nancy Starobinas
Journal:  Front Immunol       Date:  2022-02-04       Impact factor: 7.561

4.  Systemic vascular leakage induced in mice by Russell's viper venom from Pakistan.

Authors:  Alexandra Rucavado; Teresa Escalante; Erika Camacho; José María Gutiérrez; Jay W Fox
Journal:  Sci Rep       Date:  2018-10-31       Impact factor: 4.379

Review 5.  Bedside Coagulation Tests in Diagnosing Venom-Induced Consumption Coagulopathy in Snakebite.

Authors:  Supun Wedasingha; Geoffrey Isbister; Anjana Silva
Journal:  Toxins (Basel)       Date:  2020-09-10       Impact factor: 4.546

Review 6.  Systematic Review of Human Poisoning and Toxic Exposures in Myanmar.

Authors:  Meghan A Cook; Pardeep S Jagpal; Khin Hnin Pwint; Lai Lai San; Saint Saint Kyaw Thein; Thidar Pyone; Win Moh Moh Thit; Sally M Bradberry; Samuel Collins
Journal:  Int J Environ Res Public Health       Date:  2021-03-30       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.